Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Oncology Patients Receiving Chemotherapy 1 Neoplasms 1 Lung Neoplasms 1 Hypersensitivity 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

ofatumumab 1 ocrelizumab 1 obinutuzumab 1 ibritumomab tiuxetan 1 Rituximab 1 Paclitaxel 1 Diphenhydramine 1 Cetirizine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oncology Patients Receiving Chemotherapy × Cetirizine × Clear all

NCT04189588 2023-10-06

versus

TerSera Therapeutics LLC

Phase 2 Completed

34 enrolled 11 charts

Oncology Patients Receiving Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡